An experimental malaria vaccine once thought promising is turning out to be a disappointment, with a new study showing it is only about 30 percent effective at protecting infants from the killer disease.
To sign up for our daily emails, click here.
To manage your email subscriptions, click here.
Find Us On Facebook
Follow Us On Twitter